Lipids Roundtable: Administration and Adherence of New and Emerging Nonstatin Options

Access Activity

Overview / Abstract:

Target Audience
This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs.

Program Overview
This lipid roundtable will discuss the similarities and differences in various new and emerging nonstatin options.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Distinguish among current and emerging nonstatin LDL-C therapies based on unique characteristics and clinical profiles
Develop evidence-based treatment plans for at-risk patients who require additional lowering of LDL-C levels beyond statin therapy, considering patient preferences and accessibility/coverage
Discuss strategies to improve the knowledge, skills, or performance of the healthcare team

Expiration

May 12, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.25

Accreditation

ACCME, ACPE, ANCC

Presenters / Authors / Faculty

Joseph J. Saseen, PharmD, CLS, FNLA (Presenting Faculty Member)
Michelle L. O’Donoghue, MD, MPH
Daniel E. Soffer, MD, FNLA

Sponsors / Supporters / Grant Providers

Novartis Pharmaceuticals Corporation

Keywords / Search Terms

Relias LLC Relias, Free CME, Lipids Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map